Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1
The unregulated activation of STAT3 has been demonstrated to occur in many cancers and enhances tumour growth, migration, and invasion. Stimulation by cytokines, growth factors, and hormones triggers this activation by phosphorylating STAT3 at tyrosine 705. Novel imidazopyridine compounds were synth...
Main Authors: | Jung-Chen Su, Chuan-Hsun Chang, Szu-Hsien Wu, Chung-Wai Shiau |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14756366.2018.1497019 |
Similar Items
-
Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma
by: Sarita Saraswati, et al.
Published: (2019-10-01) -
Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy
by: Tzu-Ting Huang, et al.
Published: (2017-06-01) -
Liensinine suppresses STAT3-dependent HK2 expression through elevating SHP-1 to induce apoptosis in hepatocellular carcinoma cells in vitro and in vivo
by: Guangwen Shu, et al.
Published: (2018-06-01) -
Nrf2-SHP Cascade-Mediated STAT3 Inactivation Contributes to AMPK-Driven Protection Against Endotoxic Inflammation
by: Hui Gong, et al.
Published: (2020-03-01) -
Chrysin inhibits sphere formation in SMMC-7721 cells via modulation of SHP-1/STAT3 signaling pathway
by: Zhang Y, et al.
Published: (2019-04-01)